 |
인쇄하기
취소
|
Rapid approval of generic biopharmaceuticals eyed
Published: 2007-09-06 07:00:00
Updated: 2007-09-06 07:00:00
The Korea Food and Drug Administration is moving to establish a new regulation to allow the speedy product license procedures of generic biodrugs for the domestic pharmaceutical industry that is expected to be hard hit by the trade pact with the United States.
The support measures for the pharmaceutical industry will include more simplified data submission efficacy dossier on major indicati...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.